YINGBIN FU to Bevacizumab
This is a "connection" page, showing publications YINGBIN FU has written about Bevacizumab.
Connection Strength
0.047
-
Age differential response to bevacizumab therapy in choroidal neovascularization in rabbits. Exp Eye Res. 2022 10; 223:109215.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.